Maternal midpregnancy glucose levels and risk of congenital heart disease in offspring

JAMA Pediatrics

Volumn 169, Issue 12, 2015, Pages 1112-1116

  Priest, James R ^a   Yang, Wei ^a   Reaven, Gerald ^a   Knowles, Joshua W ^a   Shaw, Gary M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; FALLOT TETRALOGY; FEMALE; FETUS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GREAT VESSELS TRANSPOSITION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PHENOTYPE; PRIORITY JOURNAL; PROGENY; RADIOIMMUNOASSAY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; ANALYSIS; BLOOD; CALIFORNIA; HEART DEFECTS, CONGENITAL; NON INSULIN DEPENDENT DIABETES MELLITUS; ODDS RATIO; PREGNANCY; PREGNANCY DIABETES MELLITUS; RISK FACTOR; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; CALIFORNIA; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INSULIN; ODDS RATIO; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84964806666     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2015.2831     Document Type: Article

References (26)

1. The infants of diabetic mothers. BMJ. 1940;1 (4147):1064.
2. Rowland TW, Hubbell JP Jr, Nadas AS. Congenital heart disease in infants of diabetic mothers. J Pediatr. 1973;83(5):815-820.
3. Jenkins KJ, Correa A, Feinstein JA, et al; American Heart Association Council on Cardiovascular Disease in the Young. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):2995-3014.
4. Cousins L. Etiology and prevention of congenital anomalies among infants of overt diabetic women. Clin Obstet Gynecol. 1991;34(3):481-493.
5. Lisowski LA, Verheijen PM, Copel JA, et al. Congenital heart disease in pregnancies complicated by maternal diabetes mellitus: an international clinical collaboration, literature review, and meta-analysis. Herz. 2010;35(1):19-26.
6. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328(7445):915.
7. Lindström J, Louheranta A, Mannelin M, et al; Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230-3236.
8. Dimas AS, Lagou V, Barker A, et al; MAGIC Investigators. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes. 2014;63(6):2158-2171.
9. Schulkey CE, Regmi SD, Magnan RA, et al. The maternal-age-associated risk of congenital heart disease is modifiable. Nature. 2015;520 (7546):230-233.
10. Ariel D, Reaven G. Modulation of coronary heart disease risk by insulin resistance in subjects with normal glucose tolerance or prediabetes. Acta Diabetol. 2014;51(6):1033-1039.
11. Shaw GM, Yang W, Carmichael SL, et al. One-carbon metabolite levels in mid-pregnancy and risks of conotruncal heart defects. Birth Defects Res A Clin Mol Teratol. 2014;100(2):107-115.
12. Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem. 2012;45(6):464-469.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(suppl 1):S64-S71.
14. Dhanantwari P, Lee E, Krishnan A, et al. Human cardiac development in the first trimester: a high-resolution magnetic resonance imaging and episcopic fluorescence image capture atlas. Circulation. 2009;120(4):343-351.
15. Riskin-Mashiah S, Damti A, Younes G, Auslander R. Normal fasting plasma glucose levels during pregnancy: a hospital-based study. J Perinat Med. 2011;39(2):209-211.
16. Grewal E, Kansara S, Kachhawa G, et al. Prediction of gestational diabetes mellitus at 24 to 28 weeks of gestation by using first-trimester insulin sensitivity indices in Asian Indian subjects. Metabolism. 2012;61(5):715-720.
17. Endo S, Maeda K, Suto M, et al. Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus. Gynecol Endocrinol. 2006;22(6):343-349.
18. Hay WW Jr, Sparks JW. Placental, fetal, and neonatal carbohydrate metabolism. Clin Obstet Gynecol. 1985;28(3):473-485.
19. Beardsall K, Diderholm BMS, Dunger DB. Insulin and carbohydrate metabolism. Best Pract Res Clin Endocrinol Metab. 2008;22(1):41-55.
20. Jovanovic L, Pettitt DJ. Treatment with insulin and its analogs in pregnancies complicated by diabetes. Diabetes Care. 2007;30(suppl 2):S220-S224.
21. Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet. 2015;292(4):749-756.
22. Challier JC, Hauguel S, Desmaizieres V. Effect of insulin on glucose uptake and metabolism in the human placenta. J Clin Endocrinol Metab. 1986;62 (5):803-807.
23. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus: its role in fetal macrosomia. N Engl J Med. 1990;323(5):309-315.
24. Rask-Madsen C, Kahn CR. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2012;32(9):2052-2059.
25. Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003;24 (3):195-221.
26. Marcinkevage JA, Alverson CJ, Narayan KMV, Kahn HS, Ruben J, Correa A. Race/ethnicity disparities in dysglycemia among US women of childbearing age found mainly in the nonoverweight/nonobese. Diabetes Care. 2013;36 (10):3033-3039.